跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
diiodothyropropionic acid
首页
药物
diiodothyropropionic acid
diiodothyropropionic acid
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME
EP 4554629 A4
申请人: PRIZM LLC
优先权: 2022
EP
US
WO
4 件公开
Method for stimulating weight loss and/or for lowering triglycerides in patients
US 7504435 B2
申请人: UNIV ARIZONA
优先权: 2005
US
3 件公开
Methods for treating allan-herndon-dudley syndrome
US 12390432 B2
申请人: PRIZM LLC
优先权: 2023
US
3 件公开
Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
US 2002151594 A1
申请人: UNIV ARIZONA
优先权: 2001
US
2 件公开
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
US 8399518 B2
申请人: MORKIN EUGENE
优先权: 2008
US
2 件公开
TREATMENT OF ALLAN-HERNDON-DUDLEY SYNDROME WITH 3,5-DIIODOTHYROPROPIONIC ACID (DITPA).
WO 2012171065 A1
申请人: OGRU ESRA
优先权: 2011
WO
3,5-DIIODOTHYROPROPIONIC ACID COMPOSITIONS AND METHODS OF USE THEREOF
US 20240009157 A1
申请人: PRIZM LLC
优先权: 2023
US
METHODS AND FORMULATIONS FOR PRENATAL TREATMENT OF ALLAN-HERNDON-DUDLEY SYNDROME
US 20240009156 A1
申请人: PRIZM LLC
优先权: 2023
US
药物
反馈